Inhibition of neuronal nitric oxide synthase attenuates the development of morphine tolerance in rats

Synapse - Tập 57 Số 1 - Trang 38-46 - 2005
María Teresa Santamarta1, Isabel Ulibarri1, Joseba Pineda2
1Department of Pharmacology, Faculty of Medicine, University of the Basque Country, E-48940 Leioa, Bizkaia, Spain
2Farmakologia Saila, Medikuntza Fakultatea, Euskal Herriko Unibertsitatea (UPV/EHU), E‐48940 Leioa, Bizkaia, Spain

Tóm tắt

AbstractOur previous results have shown the involvement of nitric oxide in acute opioid desensitization of μ‐opioid receptors in vitro. In the present study, we investigated the effect of repeated administration of 7‐nitroindazole (7‐NI; 30 mg/kg/12 h, i.p., 3 days), an inhibitor of neuronal nitric oxide synthase in vivo, on μ‐opioid receptor tolerance induced by subchronic treatment with morphine in rats. The inhibitory effect of the opioid agonist Met5‐enkephalin (ME) on the cell firing rate was evaluated by single‐unit extracellular recordings of noradrenergic neurons in the locus coeruleus from brain slices, and the antinociceptive effect of morphine was measured by tail‐flick techniques. In morphine‐treated animals, concentration‐effect curves for ME in the locus coeruleus were shifted by 5‐fold to the right as compared to those in sham‐treated animals, which confirmed the induction of μ‐opioid receptor tolerance. However, tolerance to ME in morphine‐treated rats was fully prevented by co‐administration of 7‐NI when compared to the vehicle‐morphine group. Likewise, the antinociceptive effect of morphine was reduced in morphine‐treated animals as compared to the sham group, whereas the antinociceptive tolerance was partially prevented by co‐administration of 7‐NI in morphine‐treated rats (when compared to the vehicle‐morphine group). Finally, 7‐NI administration in sham‐treated rats failed to change the effect induced by ME on the locus coeruleus or by morphine in the tail‐flick test as compared to vehicle groups. These results demonstrate that subchronic administration of a neuronal inhibitor of nitric oxide synthase attenuates the development of morphine tolerance to the cellular and analgesic effects of μ‐opioid receptor agonists. Synapse 57:38–46, 2005. © 2005 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1523/JNEUROSCI.22-13-05769.2002

10.1016/0014-2999(83)90461-2

Bailey CP, 2003, Mu‐opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine, J Neurosci, 23, 10515, 10.1523/JNEUROSCI.23-33-10515.2003

10.1016/S0165-0173(03)00143-7

10.1159/000028205

10.1073/pnas.072075399

10.1016/S1044-7431(03)00173-8

10.1016/0304-3940(93)90569-7

Chou WB, 2002, M2 muscarinic receptor of spinal cord mediated increase of nNOS expression in locus coeruleus during morphine withdrawal, Acta Pharmacol Sin, 23, 691

10.1016/S0024-3205(98)00348-8

10.1007/s002130050026

De Vente J, 2002, Handbook of chemical neuroanatomy: functional neuroanatomy of the nitric oxide system, 355

10.1097/00001756-199704140-00001

10.1016/S0028-3908(98)00076-8

10.1016/0006-8993(85)90950-3

Fairbanks CA, 1997, Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance, J Pharmacol Exp Ther, 282, 1408

10.1016/S0028-3908(00)00198-2

10.1046/j.1460-9568.2003.02529.x

10.1016/S0006-8993(96)00823-2

10.1016/S0006-8993(98)00345-X

10.1016/j.bcp.2003.08.046

10.1016/0028-3908(94)90028-0

10.1002/(SICI)1098-2396(199807)29:3<233::AID-SYN5>3.0.CO;2-7

10.1146/annurev.pharmtox.39.1.191

Inoue M, 2003, Locus‐specific rescue of GluRϵ1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence, J Neurosci, 23, 6529, 10.1523/JNEUROSCI.23-16-06529.2003

10.1097/00001756-200204160-00037

10.1016/S0304-3940(96)13194-3

10.1007/BF02244904

10.1016/0014-2999(92)90261-2

10.1016/0014-2999(92)90732-J

10.1523/JNEUROSCI.17-20-07890.1997

Le Bars D, 2001, Animal models of nociception, Pharmacol Rev, 53, 597

10.1007/BF00168639

10.1016/S0165-0173(01)00057-1

10.1016/S0014-2999(99)00561-0

10.1097/00001756-199708180-00020

10.1097/00001756-199410000-00039

10.1016/0028-3908(94)90006-X

10.1016/0006-8993(94)90031-0

10.1016/S0165-0173(99)00020-X

Moncada S, 1997, XIV International union of pharmacology nomenclature in nitric oxide research, Pharmacol Rev, 49, 137

Moore PK, 1997, Selective inhibitors of neuronal nitric oxide synthase: is no NOS really good NOS for the nervous system?, Trends Pharmacol Sci, 18, 204

10.1111/j.1476-5381.1993.tb13795.x

10.1111/j.1460-9568.1997.tb01361.x

10.1126/science.278.5335.58

10.1016/0006-8993(89)91243-2

10.1016/0361-9230(94)90166-X

10.1126/science.7384811

10.1074/jbc.270.16.9052

10.1523/JNEUROSCI.16-04-01389.1996

10.1016/S0028-3908(98)00063-X

10.1016/S0006-8993(98)00066-3

10.1073/pnas.91.25.11958

Taylor DA, 2001, Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids, J Pharmacol Exp Ther, 297, 11

10.1046/j.1471-4159.1994.63051983.x

10.1097/00001756-200106130-00018

Trujillo KA, 2003, Glutamate and addiction, 295

10.1016/S0149-7634(00)00049-X

10.1016/S0306-4522(01)00426-2

10.1007/BF02245935

10.1016/S0014-2999(97)00061-7

10.1016/0306-4522(92)90184-4

10.1146/annurev.biochem.73.011303.073940

Williams JT, 1984, Opiate‐receptor interactions on single locus coeruleus neurons, Mol Pharmacol, 26, 489

Williams JT, 2001, Cellular and synaptic adaptations mediating opioid dependence, Pharmacol Rev, 81, 299

10.1093/bja/85.4.587

10.1007/BF00229111

Xu JY, 1998, The nitric/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance, J Pharmacol Exp Ther, 284, 196

10.1046/j.1460-9568.1998.00359.x